Conference Coverage

Reframing AUD as treatable may reduce stigma


 

FROM APA 2020

Addressing AUD stigma

A better understanding of the neurobiology of addiction may reduce the stigma associated with AUD, helping reframe the issue as a “health condition, rather than as a moral failing,” Dr. Koob said.

Stigma remains a major barrier to AUD treatment, he added, explaining that factors contributing to stigma include shame patients may feel for what they perceive as a personal failure, and lack of knowledge about treatment options.

Separating AUD treatment from primary care exacerbates that problem, perpetuating the sense that AUD is somehow a “different” kind of issue, he said.

Health care clinicians in primary care can help alleviate the stigma by engaging in screening and offering referral to treatment, he said, adding that the NIAAA offers a navigator website designed to help individuals negotiate the process of choosing a treatment approach for AUD.

Language matters, according to Dr. Koob, who suggested using nonstigmatizing “person-first” terminology to refer to affected individuals not as alcoholics, but as “persons with AUD.”

Challenges ahead for AUD

There’s still a lot of work to be done to understand differences in alcohol pathology between men and women, especially as gaps narrow between the sexes for AUD incidence, early-onset drinking, frequency and intensity of drinking, and self-reported consequences, Dr. Koob said.

Age differences are also important to study. On one hand, older individuals appear to be more sensitive to the effects of alcohol, he said, because of metabolism changes, neurocognitive decline, and “inflamm-aging,” or the chronic and low level inflammatory state associated with aging.

Adolescents are also an increased-risk population of research interest, since brain wiring connections are “particularly sensitive” to alcohol in the teen years, potentially setting up changes in vulnerability to AUD that last into adulthood.

Other challenges include the unmet need for better and more individualized AUD treatments, the issue of alcohol tolerance, which Dr. Koob said has been “ignored for many years” by researchers, the contribution of pain to AUD, and the way that dysregulated sleep contributes to AUD, and vice versa.

Research likewise remains “challenging” regarding conditions that are frequently found in conjunction with AUD, such as major depressive episodes, anxiety disorders, and posttraumatic stress disorder: “These are all areas that we’re intensely interested in as comorbidities with AUD,” Dr. Koob said.

Dr. Koob reported no disclosures.

SOURCE: Koob GF. APA 2020, Abstract.

Pages

Recommended Reading

For OUD patients, ‘a lot of work to be done’
MDedge Family Medicine
Cigarette smoking is associated with prefrontal function in patients with schizophrenia
MDedge Family Medicine
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
MDedge Family Medicine
A rarely discussed aspect of the opioid crisis
MDedge Family Medicine
Should physicians with OUDs return to practice after treatment?
MDedge Family Medicine
COVID-19 prompts ‘lifesaving’ policy change for opioid addiction
MDedge Family Medicine
New ASAM guideline released amid COVID-19 concerns
MDedge Family Medicine
Elderly Americans carry heavier opioid burden
MDedge Family Medicine
Researchers investigate impact of smoking on COVID-19 risk
MDedge Family Medicine
COVID-19: An opportunity, challenge for addiction treatment, NIDA boss says
MDedge Family Medicine